Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+22.98%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$8.74B
AUM Growth
+$2.28B
(+35%)
Cap. Flow
+$939M
Cap. Flow
% of AUM
10.74%
Top 10 Holdings %
Top 10 Hldgs %
23.52%
Holding
1,049
New
43
Increased
781
Reduced
144
Closed
43
Top Buys
| 1 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
$52.4M |
| 2 |
Microsoft
MSFT
|
$49M |
| 3 |
iShares MBS ETF
MBB
|
$47.2M |
| 4 |
Home Depot
HD
|
$35.9M |
| 5 |
Apple
AAPL
|
$31.9M |
Top Sells
| 1 |
Planet Fitness
PLNT
|
$22.8M |
| 2 |
McDonald's
MCD
|
$14.3M |
| 3 |
AGN
Allergan plc
AGN
|
$11.8M |
| 4 |
Ulta Beauty
ULTA
|
$11.8M |
| 5 |
Align Technology
ALGN
|
$10.2M |
Sector Composition
| 1 | Technology | 22.36% |
| 2 | Healthcare | 13% |
| 3 | Consumer Discretionary | 11.21% |
| 4 | Financials | 10.93% |
| 5 | Communication Services | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
H&R Block
HRB
$6.85B
| $189K | ﹤0.01% |
13,221
+3,120
| +31% | +$44.6K |
|
902
CONMED
CNMD
$1.7B
| $186K | ﹤0.01% |
2,585
+721
| +39% | +$51.9K |
|
|
INN
903
Summit Hotel Properties
INN
$614M
| $183K | ﹤0.01% |
30,817
+4,675
| +18% | +$27.8K |
|
904
Regenxbio
RGNX
$490M
| $183K | ﹤0.01% |
4,973
+305
| +7% | +$11.2K |
|
905
Green Dot
GDOT
$760M
| $182K | ﹤0.01% |
3,707
-474
| -11% | -$23.3K |
|
906
Vericel Corp
VCEL
$1.72B
| $179K | ﹤0.01% |
12,953
+3,746
| +41% | +$51.8K |
|
|
GOOD
907
Gladstone Commercial Corp
GOOD
$616M
| $176K | ﹤0.01% |
9,375
+1,935
| +26% | +$36.3K |
|
|
TBIO
908
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $171K | ﹤0.01% |
9,518
-7,238
| -43% | -$130K |
|
|
BBBY
909
Bed Bath & Beyond, Inc.
BBBY
$567M
| $169K | ﹤0.01% |
5,955
-10,377
| -64% | -$294K |
|
910
YPF
YPF
$12.1B
| $167K | ﹤0.01% |
29,046
| – | – |
|
911
Grifois
GRFS
$6.89B
| $163K | ﹤0.01% |
8,928
-500
| -5% | -$9.13K |
|
|
CUB
912
DELISTED
Cubic Corporation
CUB
| $163K | ﹤0.01% |
3,386
+1,464
| +76% | +$70.5K |
|
|
CLLS
913
Cellectis
CLLS
$269M
| $161K | ﹤0.01% |
+9,038
| New | +$161K |
|
|
LX
914
LexinFintech Holdings
LX
$1.02B
| $161K | ﹤0.01% |
15,126
+5,687
| +60% | +$60.5K |
|
|
BPYU
915
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $160K | ﹤0.01% |
16,070
-456
| -3% | -$4.54K |
|
916
Ligand Pharmaceuticals
LGND
$3.25B
| $158K | ﹤0.01% |
2,270
+292
| +15% | +$20.3K |
|
917
Sangamo Therapeutics
SGMO
$165M
| $158K | ﹤0.01% |
17,689
-427
| -2% | -$3.81K |
|
|
RPT
918
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $157K | ﹤0.01% |
22,517
| – | – |
|
|
CIO
919
City Office REIT
CIO
$280M
| $152K | ﹤0.01% |
15,128
+90
| +0.6% | +$904 |
|
920
Under Armour Class C
UA
$2.13B
| $152K | ﹤0.01% |
17,186
-28,305
| -62% | -$250K |
|
921
Sanofi
SNY
$113B
| $151K | ﹤0.01% |
2,956
+160
| +6% | +$8.17K |
|
|
FSP
922
Franklin Street Properties
FSP
$174M
| $149K | ﹤0.01% |
29,223
| – | – |
|
923
Krystal Biotech
KRYS
$4.35B
| $148K | ﹤0.01% |
3,575
+241
| +7% | +$9.98K |
|
924
Iridium Communications
IRDM
$2.67B
| $146K | ﹤0.01% |
5,735
+347
| +6% | +$8.83K |
|
|
IMMU
925
DELISTED
Immunomedics Inc
IMMU
| $146K | ﹤0.01% |
4,106
-3,020
| -42% | -$107K |
|